The Clinical Impact of Negative Syndromic Testing Results

The BioFire® FilmArray® Meningitis/Encephalitis (ME) Panel has been shown to rapidly identify the most common central nervous system pathogens, leading to better patient outcomes. But what does a negative result on a highly sensitive syndromic panel mean for patient care? Dr. Rodrigo Hasbun, MD, MPH, FIDSA, reviews the current standard of care without the use of the BioFire ME Panel; evaluates the sensitivity of a negative BioFire ME Panel for bacteria, viruses, and cryptococcus; and discusses the potential clinical impact of a negative BioFire ME Panel result.

BFR0000 7080 The Clinical Impact of Negative Syndromic Testing Results Video

Видео The Clinical Impact of Negative Syndromic Testing Results канала BioFire Diagnostics